<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02503046</url>
  </required_header>
  <id_info>
    <org_study_id>D139206062</org_study_id>
    <nct_id>NCT02503046</nct_id>
  </id_info>
  <brief_title>Estimation of Pentraxin3 and PGingivalis Levels in Patients With Knee Joint and Gum Diseases</brief_title>
  <acronym>EP3PGKG</acronym>
  <official_title>Estimation of Pentraxin 3 and Porphyromonas Gingivalis Levels in Patients With Rheumatoid Arthritis and Periodontitis- An Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Panineeya Mahavidyalaya Institute of Dental Sciences &amp; Research Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Panineeya Mahavidyalaya Institute of Dental Sciences &amp; Research Centre</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Periodontitis and Rhematoid arthritis are chronic inflammatory diseases which share common
      risk factors The purpose of this study is to determine if Pentraxin 3 and Porphyromonas
      Gingivalis levels play an important role in the progression of both the diseases.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Periodontal disease progression might play a significant role in the severity and outcome of
      systemic diseases like rheumatoid arthritis. Pentraxin3 is a newly discovered inflammatory
      biomarker. It is a member of acute phase proteins and it has been observed from previous
      studies that plasma pentraxin3 levels have increased with increasing severity of cardiac and
      renal problems.

      Porphyromonas gingivalis proteinase is responsible for the epitope development in RF-Fc
      region These proteinases are important virulence factors which lead to degradation of host
      tissue. Porphyromonas gingivalis is also a key periodonto pathogen. Thus the aim of this
      study is to compare the plasma pentraxin3 and p.gingivalis levels in patients with
      periodontitis and rheumatoid arthritis.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">November 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Estimation of Plasma Pentraxin 3 levels.</measure>
    <time_frame>7 Months</time_frame>
    <description>5ml of blood collected from each subject and centrifuged to separate plasma for estimation of Pentraxin3 levels (Quantikine ELISA)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Estimation of P.Gingivalis levels.</measure>
    <time_frame>7 Months</time_frame>
    <description>Pooled plaque samples to be collected and sent for DNA Extraction by PCR to estimate the levels of PGingivalis</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">90</enrollment>
  <condition>Rheumatoid Arthritis</condition>
  <condition>Chronic Periodontitis</condition>
  <arm_group>
    <arm_group_label>Arthritis with Periodontitis</arm_group_label>
    <description>Patients aged between 30-65 years with 6 positive diagnostic criteria for Rhematoid Arthritis. Patients should have Clinical attachment loss &gt;6mm, and Probing pocket depth&gt;5mm in more than 6 teeth to satisfy criteria for periodontitis.
5ml of blood to be collected from each patient, centrifuged and plasma extracted used for estimation of Pentraxin3(Quantikine ELISA) Pooled plaque sample taken,DNA extracted by PCR for estimation of P.Gingivalis levels.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Periodontitis group</arm_group_label>
    <description>Patients aged between 30-65 years with Periodontal findings being presence of atleast 20 teeth in the mouth .More than 6 teeth with Clinical attachment loss &gt;6mm and Probing pocket depth&gt;5mm to satisfy criteria for periodontitis. 5ml of blood to be collected from each patient, centrifuged and plasma extracted used for estimation of Pentraxin3(Quantikine ELISA).
Pooled plaque sample taken,DNA extracted by PCR for estimation of P.Gingivalis levels..</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Subjects</arm_group_label>
    <description>Subjects aged between 30-65 years with no systemic diseases and periodontitis. 5ml of blood to be collected from each patient, centrifuged and plasma extracted used for estimation of Pentraxin3(Quantikine ELISA).
Pooled plaque sample taken,DNA extracted by PCR for estimation of P.Gingivalis levels..</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Estimation of Pentraxin3</intervention_name>
    <description>5ml of blood to be collected from each subject, centrifuged, to separate the plasma for estimation of Pentraxin3 (Quantikine ELISA)</description>
    <arm_group_label>Arthritis with Periodontitis</arm_group_label>
    <arm_group_label>Periodontitis group</arm_group_label>
    <arm_group_label>Healthy Subjects</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Estimation of P.Gingivalis levels</intervention_name>
    <description>Pooled plaque sample will be collected and sent for DNA Extraction by PCR for assessment of levels of PGingivalis</description>
    <arm_group_label>Arthritis with Periodontitis</arm_group_label>
    <arm_group_label>Periodontitis group</arm_group_label>
    <arm_group_label>Healthy Subjects</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Pooled plaque sample will be collected and sent for DNA Extraction by PCR for asseessment of
      levels of PGingivalis.

      5ml of blood to be collected from each subject, centrifuged, to separate the plasma for
      estimation of Pentraxin3 (Quantikine ELISA)
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Total 90 Subjects of whom 30 subjects belong to the Arthritis and Periodontitis group,30
        subjects belong to the Periodontitis group and 30 subjects from the healthy group
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        30 Patients with rheumatoid arthritis and periodontitis 30 Patients with Chronic
        periodontitis only 30 Healthy subjects Patients with six positive diagnostic criteria for
        RA,morning stiffness,at least three areas of swollen joints,arthritis of hand
        joints,symmetric arthritis,rheumatoid nodules,serum rheumatoid factor.

        For periodontal findings patients aged ≥30yrs,attachment level ≥6mm,at least 20 teeth
        should present, ≥ 2 sites with pocket depths ≥ 5mm

        Exclusion Criteria:

        Patients with aggressive periodontitis, Smokers, with gross oral pathology or tumors, with
        any systemic disorder other than rheumatoid arthritis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shankar Gittaboyina, PG(Perio)</last_name>
    <role>Principal Investigator</role>
    <affiliation>Panineeya Mahavidhyalaya Institute of Dental Sciences and Research Centre</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rekha R Koduganti, MDS(Perio)</last_name>
    <role>Study Director</role>
    <affiliation>Panineeya Mahavidhyalaya Institute of Dental Sciences and Research Centre</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Panineeya Mahavidhyalaya Institute of Dental Sciences and Research Centre</name>
      <address>
        <city>Hyderabad</city>
        <state>Telangana</state>
        <zip>500060</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <reference>
    <citation>Bartold PM, Marino V, Cantley M, Haynes DR. Effect of Porphyromonas gingivalis-induced inflammation on the development of rheumatoid arthritis. J Clin Periodontol. 2010 May;37(5):405-11. doi: 10.1111/j.1600-051X.2010.01552.x.</citation>
    <PMID>20507365</PMID>
  </reference>
  <reference>
    <citation>Luchetti MM, Piccinini G, Mantovani A, Peri G, Matteucci C, Pomponio G, Fratini M, Fraticelli P, Sambo P, Di Loreto C, Doni A, Introna M, Gabrielli A. Expression and production of the long pentraxin PTX3 in rheumatoid arthritis (RA). Clin Exp Immunol. 2000 Jan;119(1):196-202.</citation>
    <PMID>10606983</PMID>
  </reference>
  <reference>
    <citation>Mercado FB, Marshall RI, Klestov AC, Bartold PM. Relationship between rheumatoid arthritis and periodontitis. J Periodontol. 2001 Jun;72(6):779-87.</citation>
    <PMID>11453241</PMID>
  </reference>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 15, 2015</study_first_submitted>
  <study_first_submitted_qc>July 16, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 20, 2015</study_first_posted>
  <last_update_submitted>August 26, 2016</last_update_submitted>
  <last_update_submitted_qc>August 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Panineeya Mahavidyalaya Institute of Dental Sciences &amp; Research Centre</investigator_affiliation>
    <investigator_full_name>Dr.G.Shankar</investigator_full_name>
    <investigator_title>PG Student</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Chronic Periodontitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

